![Zorbtive [somatropin (rDNA origin) for injection]](images/Zorbtive_180.png)
The potential for less
PN dependence
People with SBS who
were treated with
Zorbtive—a study summary
What some people
experienced after treatment
 |
| “I like the idea that more of what I need comes from the food I eat.” |
Zorbtive® [somatropin (rDNA origin) for injection] is the first and only drug treatment approved by the Food and Drug Administration (FDA) for treatment of people with Short Bowel Syndrome (SBS) who are receiving specialized nutritional support.
Zorbtive is growth hormone similar to the growth hormone produced by the pituitary gland in your body.
Zorbtive is for people with SBS who rely on a special diet which may include parenteral nutrition (PN).
Zorbtive potentially helps people whose shortened or damaged small intestine can no longer absorb enough fluids and nutrients from a “regular” oral diet.
Zorbtive may be prescribed by your doctor if:
- you have been diagnosed with Short Bowel Syndrome, and
- you are stable on a special oral diet.
The potential for less PN dependence
People with SBS who were treated with Zorbtive—a study summary
What some people experienced after treatment
Frequently asked questions
Home
Zorbtive® [somatropin (rDNA origin) for injection] is indicated for the treatment of Short Bowel Syndrome (SBS) in patients receiving specialized nutritional support. Optimal management of SBS may include dietary adjustments, enteral feedings, parenteral nutrition, and fluid and micronutrient supplements, as needed.
Some common side effects of Zorbtive treatment include muscle and joint pain, and fluid retention (swelling).
Zorbtive may also cause serious side effects such as inflammation of the pancreas (pancreatitis), diabetes or
other blood sugar problems, pain, numbness or tingling in the wrist and hand, or increased blood pressure
in the brain. Make sure and talk with your doctor about these side effects.
Do not take Zorbtive if you have any of the following serious medical conditions: open-heart surgery; stomach-area (abdominal) surgery; an accident; breathing problems (respiratory failure); cancer; or, allergy to Zorbtive or other growth hormone medications.
This information is not intended to replace discussions with your healthcare professional.
For additional information about Zorbtive, please read the Zorbtive Patient Information Leaflet
and Zorbtive Full Prescribing Information and talk to your doctor. You can also call SeroCareSM
toll free at 800-714-2437. Zorbtive is available by prescription only.
This Web site was developed by EMD Serono, Inc. (emdserono.com), makers of Zorbtive, to educate SBS patients
and interested healthcare professionals about this treatment for Short Bowel Syndrome.
This site contains medical information that is intended for residents of the United States
only and is not meant to substitute for the advice provided by a medical professional.
Always consult a doctor if you have health concerns. Use and access of this
site is subject to the terms and conditions as set out in our Legal Statement
and Privacy Policy.
© 2007 EMD Serono, Inc. All rights reserved. 